Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics/-Dynamics of AK1967 (Procizumab)

Clinical trial NCT06331884 · COMPLETED

Trial details

NCT number: NCT06331884
Sponsor: 4TEEN4 Pharmaceuticals GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Safety and Tolerability Healthy Volunteers

Start date: 2024-03-07
Primary completion: 2024-08-05
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.